Technical Analysis for ACHV - Achieve Life Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 4.71 | -0.53% | -0.03 |
ACHV closed down 0.53 percent on Wednesday, May 8, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
180 Bullish Setup | Bullish Swing Setup | -0.53% | |
Upper Bollinger Band Walk | Strength | -0.53% | |
Inside Day | Range Contraction | -0.53% | |
Upper Bollinger Band Touch | Strength | -0.53% | |
20 DMA Support | Bullish | 2.95% | |
200 DMA Support | Bullish | 2.95% |
Alert | Time |
---|---|
Possible NR7 | about 20 hours ago |
Upper Bollinger Band Resistance | about 21 hours ago |
Reversed from Down | about 22 hours ago |
60 Minute Opening Range Breakout | about 22 hours ago |
Bullish 180 Entry | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Breast Cancer Prostate Cancer Non Small Cell Lung Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Oncolytics Biotech Apatorsen
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.25 |
52 Week Low | 3.03 |
Average Volume | 120,994 |
200-Day Moving Average | 4.55 |
50-Day Moving Average | 4.50 |
20-Day Moving Average | 4.54 |
10-Day Moving Average | 4.61 |
Average True Range | 0.22 |
RSI (14) | 56.90 |
ADX | 8.52 |
+DI | 14.97 |
-DI | 14.68 |
Chandelier Exit (Long, 3 ATRs) | 4.16 |
Chandelier Exit (Short, 3 ATRs) | 4.85 |
Upper Bollinger Bands | 4.77 |
Lower Bollinger Band | 4.31 |
Percent B (%b) | 0.86 |
BandWidth | 10.24 |
MACD Line | 0.05 |
MACD Signal Line | 0.03 |
MACD Histogram | 0.0204 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.92 | ||||
Resistance 3 (R3) | 4.92 | 4.85 | 4.89 | ||
Resistance 2 (R2) | 4.85 | 4.79 | 4.85 | 4.87 | |
Resistance 1 (R1) | 4.78 | 4.76 | 4.81 | 4.78 | 4.86 |
Pivot Point | 4.70 | 4.70 | 4.72 | 4.70 | 4.70 |
Support 1 (S1) | 4.63 | 4.65 | 4.67 | 4.63 | 4.55 |
Support 2 (S2) | 4.56 | 4.61 | 4.56 | 4.54 | |
Support 3 (S3) | 4.49 | 4.56 | 4.52 | ||
Support 4 (S4) | 4.49 |